Abeona Therapeutics
(NASDAQ) ABEO
Abeona Therapeutics Financials at a Glance
Market Cap
$253.87M
Revenue (TTM)
$5.82M
Net Income (TTM)
$71.18M
EPS (TTM)
$1.00
P/E Ratio
4.46
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$4.46
Volume
41,800
Open
$4.55
Price
$4.46
Volume
41,800
Open
$4.55
Previous Close
$4.46
Daily Range
$4.43 - $4.57
52-Week Range
$3.93 - $7.54
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$4.46
Volume
41,800
Open
$4.55
Previous Close
$4.46
Daily Range
$4.43 - $4.57
52-Week Range
$3.93 - $7.54
ABEO News
ABEO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abeona Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
226
CEO
Vishwas Seshadri, PhD, MBA
Website
www.abeonatherapeutics.comHeadquarters
Cleveland, NY 10019, US
ABEO Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
-15%
Net Income Margin
12%
Return on Equity
70%
Return on Capital
-47%
Return on Assets
32%
Earnings Yield
22.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$253.87M
Shares Outstanding
57.05M
Volume
41.80K
Short Interest
0.00%
Avg. Volume
1.21M
Financials (TTM)
Gross Profit
$4.29M
Operating Income
$89.45M
EBITDA
$85.89M
Operating Cash Flow
$76.33M
Capital Expenditure
$7.97M
Free Cash Flow
$84.30M
Cash & ST Invst.
$191.40M
Total Debt
$24.97M
Abeona Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.42M
N/A
Gross Profit
$1.72M
+321.6%
Gross Margin
31.73%
N/A
Market Cap
$253.87M
N/A
Market Cap/Employee
$1.87M
N/A
Employees
136
N/A
Net Income
$20.46M
-120.2%
EBITDA
$183.17M
-2363.0%
Quarterly Fundamentals
Net Cash
$166.44M
+122.9%
Accounts Receivable
$6.71M
+306.5%
Inventory
$5.49M
N/A
Long Term Debt
$11.88M
-27.1%
Short Term Debt
$13.09M
+93.9%
Return on Assets
32.42%
N/A
Return on Invested Capital
-47.08%
N/A
Free Cash Flow
$19.11M
-11.3%
Operating Cash Flow
$17.95M
-8.4%